Biomarker-Positive Disease: Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.

Led by experts Dr. Jaime L. Schneider, Dr. Solange Peters and Dr. Lizza Hendriks, this CME-accredited program is for healthcare professionals involved in the clinical management of patients with non-small cell lung cancer (NSCLC) and other cancers. Learn about the advent and impact of precision oncology, the process and significance of biomarker-testing for cancers with tumor-agnostic mutations, the dynamic progression of targeted therapies, and the potential challenges and future trajectory of biomarker testing.
Access a downloadable transcript of this webinar at targeted-thera...
This webinar is part is part of an ACCME- and EACCME-accredited, Independent Medical Education program entitled, Biomarker-Positive Disease: A Personalized Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.
To learn more about the full program or to CLAIM YOUR CREDITS, visit targeted-thera...
---
This activity is supported by independent educational grants from Roche and Illumina.